The influence of antiepileptic drugs on cognition: a comparison of levetiracetam with topiramate. (Q51976410)

19 April 2018

title

The influence of antiepileptic drugs on cognition: a comparison of levetiracetam with topiramate. (English)

1 reference

19 April 2018

1 reference

Andreas Schulze-Bonhage

object named as

Andreas Schulze-Bonhage

1 reference

19 April 2018

Bettina Gomer

1 reference

19 April 2018

Kathrin Wagner

1 reference

19 April 2018

Lars Frings

1 reference

19 April 2018

Josef Saar

1 reference

19 April 2018

Astrid Carius

1 reference

19 April 2018

Markus Härle

1 reference

19 April 2018

Bernhard J Steinhoff

1 reference

19 April 2018

publication date

3 April 2007

1 reference

19 April 2018

published in

Epilepsy Behavior

1 reference

19 April 2018

volume

1 reference

19 April 2018

issue

1 reference

19 April 2018

page(s)

486-494

1 reference

19 April 2018

Cognitive and behavioral effects of epilepsy treatment

cites work

1 reference

https://api.crossref.org/works/10.1016%2FJ.YEBEH.2007.02.007

Effect of levetiracetam on epilepsy-related quality of life. N132 Study Group.

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.YEBEH.2007.02.007

Clinical experience of levetiracetam monotherapy for adults with epilepsy: 1-year follow-up study.

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.YEBEH.2007.02.007

Efficacy and tolerability of levetiracetam 3000 mg/d in patients with refractory partial seizures: a multicenter, double-blind, responder-selected study evaluating monotherapy. European Levetiracetam Study Group

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.YEBEH.2007.02.007

Multicenter double-blind, randomized, placebo-controlled trial of levetiracetam as add-on therapy in patients with refractory partial seizures. European Levetiracetam Study Group

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.YEBEH.2007.02.007

Levetiracetam in a broad population of patients with refractory epilepsy: interim results of the international SKATE trial.

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.YEBEH.2007.02.007

Predicting drug-resistant patients who respond to add-on therapy with levetiracetam

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.YEBEH.2007.02.007

The KEEPER trial: levetiracetam adjunctive treatment of partial-onset seizures in an open-label community-based study

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.YEBEH.2007.02.007

Efficacy and tolerability of the new antiepileptic drugs II: treatment of refractory epilepsy: report of the Therapeutics and Technology Assessment Subcommittee and Quality Standards Subcommittee of the American Academy of Neurology and the [...]

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.YEBEH.2007.02.007

The long term retention of levetiracetam in a large cohort of patients with epilepsy.

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.YEBEH.2007.02.007

A systematic review of the behavioral effects of levetiracetam in adults with epilepsy, cognitive disorders, or an anxiety disorder during clinical trials.

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.YEBEH.2007.02.007

Aggressive behavior of epilepsy patients in the course of levetiracetam add-on therapy: report of 33 mild to severe cases

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.YEBEH.2007.02.007

Psychiatric adverse events during levetiracetam therapy

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.YEBEH.2007.02.007

Neuropsychological and psychiatric impact of add-on titration of pregabalin versus levetiracetam: a comparative short-term study

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.YEBEH.2007.02.007

Cognitive and memory effects of the new antiepileptic drugs

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.YEBEH.2007.02.007

Clinical, cognitive, and neurophysiologic correlates of short-term treatment with carbamazepine, oxcarbazepine, and levetiracetam in healthy volunteers

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.YEBEH.2007.02.007

Cognitive effects of a new pyrrolidine derivative (levetiracetam) in patients with epilepsy.

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.YEBEH.2007.02.007

Levetiracetam: an improvement of attention and of oral fluency in patients with partial epilepsy

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.YEBEH.2007.02.007

Double-blind, placebo-controlled trial of topiramate as add-on therapy in patients with refractory partial seizures

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.YEBEH.2007.02.007

Topiramate as add-on therapy: pooled analysis of randomized controlled trials in adults

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.YEBEH.2007.02.007

Postmarketing experience with topiramate and cognition

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.YEBEH.2007.02.007

Cognitive impairments due to add-on therapy with topiramate

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.YEBEH.2007.02.007

The effects of adjunctive topiramate on cognitive function in patients with epilepsy

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.YEBEH.2007.02.007

Effects of topiramate on cognitive function

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.YEBEH.2007.02.007

Effects of topiramate and gabapentin on cognitive abilities in healthy volunteers

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.YEBEH.2007.02.007

Cognitive profile of topiramate as compared with lamotrigine in epilepsy patients on antiepileptic drug polytherapy: relationships to blood serum levels and comedication

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.YEBEH.2007.02.007

A multicenter, randomized clinical study to evaluate the effect on cognitive function of topiramate compared with valproate as add-on therapy to carbamazepine in patients with partial-onset seizures.

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.YEBEH.2007.02.007

Significant improvement in frontal lobe associated neuropsychological functions after withdrawal of topiramate in epilepsy patients

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.YEBEH.2007.02.007

Normative data and screening power of a shortened version of the Token Test

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.YEBEH.2007.02.007

Improvement of a patient with stuttering on levetiracetam

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.YEBEH.2007.02.007

10.1016/J.YEBEH.2007.02.007

7 January 2021

Identifiers

DOI

1 reference

19 April 2018

1 reference

19 April 2018